Global Patent Index - EP 3145500 A1

EP 3145500 A1 20170329 - CELECOXIB FORMULATIONS USEFUL FOR TREATING COLORECTAL CANCER

Title (en)

CELECOXIB FORMULATIONS USEFUL FOR TREATING COLORECTAL CANCER

Title (de)

ZUR BEHANDLUNG VON KOLOREKTALEM KREBS NÜTZLICHE CELECOXIBFORMULIERUNGEN

Title (fr)

PRÉPARATIONS DE CÉLÉCOXIB UTILES POUR TRAITER UN CANCER COLORECTAL

Publication

EP 3145500 A1 20170329 (EN)

Application

EP 14728123 A 20140523

Priority

EP 2014060750 W 20140523

Abstract (en)

[origin: WO2015176780A1] An oral celecoxib formulation, the formulation being a multiple minibead formulation wherein the minibeads comprise a hydrogel-forming polymer matrix in which are distributed celecoxib, a polyoxyethylated non-ionic surfactant and an anionic surfactant, the minibeads when combined with water being capable of releasing self-assembly structures comprising surfactant and celecoxib. The formulation may be used for treating colorectal cancer, e.g. for inhibiting, reducing or delaying the initiation and/or progression of colorectal cancer, or for use in reversing colorectal cancer, reducing the burden of colorectal cancer and/or inducing remission of colorectal cancer, or for inhibiting, reducing or delaying metastasis of a colorectal cancer.

IPC 8 full level

A61K 9/50 (2006.01); A61K 31/00 (2006.01)

CPC (source: EP)

A61K 9/5057 (2013.01); A61K 9/5089 (2013.01); A61K 31/415 (2013.01); A61P 35/00 (2017.12); A61P 35/04 (2017.12)

Citation (search report)

See references of WO 2015176780A1

Designated contracting state (EPC)

AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

Designated extension state (EPC)

BA ME

DOCDB simple family (publication)

WO 2015176780 A1 20151126; CA 2872201 A1 20151123; EP 3145500 A1 20170329

DOCDB simple family (application)

EP 2014060750 W 20140523; CA 2872201 A 20141126; EP 14728123 A 20140523